Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SafeDoxyPEP trial
2023-507137-24-00Phase 2Completed
- Sponsor
- Institute of Tropical Medicine Antwerp
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of doxycycline in Chlamydia trachomatis infection, gonorrhea and syphilis, sponsored by Institute of Tropical Medicine Antwerp. Started Jan 2024; status: completed.
02
Drugs
doxycycline
03
Conditions
Chlamydia trachomatis infectiongonorrheasyphilis
Beyond the preview
Go deeper on 2023-507137-24-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-507137-24-00.